Literature DB >> 15752743

The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles.

Marc Douaisi1, Sylvie Dussart, Marianne Courcoul, Gilles Bessou, Edwina C Lerner, Etienne Decroly, Robert Vigne.   

Abstract

The main function of Vif is to limit the antiviral activity of APOBEC3G by counteracting its packaging into HIV-1 virions. In this work, we examine the possible functional interactions between Vif, APOBEC3G, and two Src family tyrosine kinases, Fyn and Hck, present in T lymphocytes and in monocyte-macrophages, respectively. By GST pull-down, we show that the SH3 domains of Fyn and Hck, and the corresponding full-length proteins bind Vif of HIV-1. One consequence of this interaction is a reduction in their catalytic activity. Interestingly, we also observed that APOBEC3G can be phosphorylated on tyrosine in the presence of Fyn or Hck, suggesting that both kinases may regulate APOBEC3G function. Accordingly, we demonstrate that in the presence of Fyn or Hck and in the absence of Vif, the overall level of APOBEC3G incorporated into HIV-1 particles is decreased, whereas the level of encapsidation of its phosphorylated form is significantly enhanced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752743     DOI: 10.1016/j.bbrc.2005.02.057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.

Authors:  Iris Cadima-Couto; Nuno Saraiva; Ana Catarina C Santos; Joao Goncalves
Journal:  J Neuroimmune Pharmacol       Date:  2011-01-29       Impact factor: 4.147

2.  Characterization of RNA binding and chaperoning activities of HIV-1 Vif protein. Importance of the C-terminal unstructured tail.

Authors:  Dona Sleiman; Serena Bernacchi; Santiago Xavier Guerrero; Franck Brachet; Valéry Larue; Jean-Christophe Paillart; Carine Tisne
Journal:  RNA Biol       Date:  2014-07-22       Impact factor: 4.652

3.  On the solution conformation and dynamics of the HIV-1 viral infectivity factor.

Authors:  Sean R Marcsisin; Purushottam S Narute; Lori A Emert-Sedlak; Marek Kloczewiak; Thomas E Smithgall; John R Engen
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

4.  Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.

Authors:  William M McDougall; Harold C Smith
Journal:  Biochem Biophys Res Commun       Date:  2011-08-11       Impact factor: 3.575

5.  Partial cooperative unfolding in proteins as observed by hydrogen exchange mass spectrometry.

Authors:  John R Engen; Thomas E Wales; Shugui Chen; Elaine M Marzluff; Kerry M Hassell; David D Weis; Thomas E Smithgall
Journal:  Int Rev Phys Chem       Date:  2013-01-01       Impact factor: 4.762

6.  Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

Authors:  Rebecca A Russell; Vinay K Pathak
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

7.  HIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenon.

Authors:  Alyssa Cornall; Johnson Mak; Alison Greenway; Gilda Tachedjian
Journal:  Viruses       Date:  2013-09-18       Impact factor: 5.048

8.  Towards Inhibition of Vif-APOBEC3G Interaction: Which Protein to Target?

Authors:  Iris Cadima-Couto; Joao Goncalves
Journal:  Adv Virol       Date:  2010-09-21

9.  Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.

Authors:  David M Lehmann; Chad A Galloway; Mark P Sowden; Harold C Smith
Journal:  Nucleic Acids Res       Date:  2006-07-04       Impact factor: 16.971

10.  The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.

Authors:  Sandrina Dafonseca; Pascale Coric; Bernard Gay; Saw See Hong; Serge Bouaziz; Pierre Boulanger
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.